Detalles de la búsqueda
1.
Prognostic Impact of CD38- and IgκC-Positive Tumor-Infiltrating Plasma Cells in Triple-Negative Breast Cancer.
Int J Mol Sci
; 24(20)2023 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37894900
2.
G-8 Geriatric Screening Tool Independently Predicts Progression-Free Survival in Older Ovarian Cancer Patients Irrespective of Maximal Surgical Effort: Results of a Retrospective Cohort Study.
Gerontology
; 68(10): 1101-1110, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34875663
3.
Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes.
Int J Mol Sci
; 21(19)2020 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33003293
4.
Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.
Int J Med Sci
; 16(9): 1188-1198, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31588183
5.
A retrospective analysis of immunohistochemically determined IRF4 (interferon regulating factor 4) expression in a consecutive cohort of 114 ovarian cancer patients.
Arch Gynecol Obstet
; 299(1): 239-246, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30357498
6.
Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population.
Breast Cancer Res
; 20(1): 15, 2018 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29482642
7.
Validation of a two-tier grading system in an unselected, consecutive cohort of serous ovarian cancer patients.
Arch Gynecol Obstet
; 294(3): 599-606, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26993518
8.
Management of recurrent or metastatic endometrial cancer in Germany: results of the nationwide AGO pattern of care studies from the years 2013, 2009 and 2006.
Arch Gynecol Obstet
; 292(6): 1355-60, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099624
9.
Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers.
Cancers (Basel)
; 16(7)2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38611049
10.
Efficacy of pembrolizumab in advanced cancer of the vulva: a systematic review and single-arm meta-analysis.
Front Oncol
; 14: 1352975, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38440225
11.
Anti-tumor effects of low-dose metronomic vinorelbine in combination with alpelisib in breast cancer cells.
EXCLI J
; 22: 114-130, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36998707
12.
Real-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study.
Breast Care (Basel)
; 18(2): 97-105, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37261128
13.
Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer.
Cancers (Basel)
; 15(5)2023 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900203
14.
Current Approaches to the Management of Sentinel Node Procedures in Early Vulvar Cancer in Germany: A Web-Based Nationwide Analysis of Practices.
J Clin Med
; 12(5)2023 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36902834
15.
Resilience as a Source of Easement to Health-Related Worries in Women at Increased Risk for Breast or Ovarian Cancer During the COVID-19 Pandemic.
Int J Gen Med
; 15: 7039-7052, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36090707
16.
Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancer.
Eur J Cancer
; 173: 10-19, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35839597
17.
Prognostic Impact of LAG-3 mRNA Expression in Early Breast Cancer.
Biomedicines
; 10(10)2022 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36289918
18.
Immunomodulating Therapies in Breast Cancer-From Prognosis to Clinical Practice.
Cancers (Basel)
; 13(19)2021 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638367
19.
Prognostic Impact of Immunoglobulin Kappa C in Breast Cancer Patients Treated with Adjuvant Chemotherapy.
Breast Care (Basel)
; 16(5): 444-451, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34720803
20.
The Impact of Insulin on Low-dose Metronomic Vinorelbine and Mafosfamide in Breast Cancer Cells.
Anticancer Res
; 41(3): 1243-1250, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33788715